In this second decade of the 21st century, we find the pervasive influence of synthetic biology everywhere, not only in research laboratories, but also in the discourses of politicians and ethicists. Despite its ubiquity, the precise meaning of the notions of "synthetic biology" and "synthetic life," as well as their history, potential, and risks, remain obscure not only to the layperson, but also to most biologists.
The aim of this special issue is twofold. First, it is intended to help the reader better appreciate what synthetic biology is all about and what are its roots. Second, once the overall picture has been expounded and made clearer, the questions of whether research in synthetic biology raises new and specific ethical issues, and how to control the experiments in this field, can be based on a firmer ground.
François Jacob argued that the best way to know what molecular biology really is, is to look at what molecular biologists do in their laboratories.We have adopted the same strategy here.Therefore, the first three contributions describe different and complementary aspects of research pursued in synthetic biology.
It is naturally proper to commence this overview with the experiment that has had the most obvious media impact: the production by Craig Venter's group of a bacterial cell with a chemically synthesized genome. John Glass, who was closely associated with the project from its beginnings, describes not only the obstacles that had to be overcome to reach this outcome, but also underlines the fact that the experiment consists of two different steps, each endowed with its own difficulties: the chemical synthesis of a full-length genome, and its transplantation into a recipient bacterium. This successful experiment is as much a beginning as it is an achievement: it opens the possibility of constructing the minimal genome compatible with life, and through this of casting new light on the nature of life. This top-down approach to a definition of life is complemented by other bottom-up work done in synthetic biology, aiming at progressively introducing in simple physicochemical systems what is required to generate "living systems."
Editors' Introduction to Special Issue
Wilfried Weber and his colleagues describe another dimension of synthetic biology, its ambition to engineer (program) cells for biological and biomedical applications. The latter can be highly diverse, from mimicking host-parasite interactions to efficiently screening new drugs against tuberculosis.
Gregory Linshiz and his colleagues go a step further and suggest that the development of synthetic biology is nothing less than a scientific revolution. It requires the fusion of biology with computer science and engineering, a new breed of scientists, the construction of a new language of communication, and a new division of labor. Linshiz's contribution also points to the second strategy that we have used to determine what synthetic biology is: we positioned it in the historical development of biological knowledge, in order to appreciate its true novelty. This approach shows that reflections and research on the synthesis of life in the laboratory are much older and broader in scope than the extant synthetic biology.
Ute Deichmann reminds us that the refutation at the end of the 19th century of the spontaneous generation of life, and of crystallizing cells from inanimate matter, by Pasteur, Remak, and Virchow, to mention only the most prominent researchers, was a prerequisite for the start of numerous projects targeted at synthesizing life. These projects were guided by very different central conceptions, such as growth and form on the one hand, and specificity of organisms' molecules and reactions on the other. However, Deichmann does not support relativistic views, showing that though morphological-mathematical approaches succeeded to mimic certain properties of life, the underlying conceptions turned out not to be fruitful. All extant projects are based on the specificity of macromolecules as the basis of life.
To understand what exactly synthetic biology is also requires an exposition of what, clearly, it is not. Michel Morange shows that the recurrent discourse among some synthetic biologists who claim that they will improve the functions of organisms and do what evolution was unable to accomplish does not correspond to reality. Further, synthetic biology uses evolution to optimize the systems designed by researchers, and synthetic biology is a wonderful tool to address evolutionary issues. In fact, organisms are more and more considered by engineers as a source of inspiration: the long-standing comparison between organisms and machines is now running in the opposite direction.
Ulrich Charpa, in similar vein, argues that using the metaphor of the Golem to explain the productions of synthetic biologists is misleading. Its use obscures the nature of synthetic biology and the ethical debates raised by new developments in biology.The statement that synthetic biologists are "playing God" also does not make sense.
Both Shimon Glick and David Heyd reach a similar conclusion: neither in the light of the Jewish tradition nor in the philosophical approach to ethical issues is there anything special in the work of synthetic biologists. The benefit/cost ratio remains the guide for appreciating the value of the projects developed in this discipline.To prevent its development in the name of a "precautionary principle" would be a disaster.
This does not mean that synthetic biology should not deserve special attention-the main reason it does is because it is a new approach to biological phenomena, and it is still difficult to anticipate what will result from its development. But there are additional reasons to be vigilant, as described by Bracha Rager-Zisman. Most of the experiments done in synthetic biology are relatively simple and inexpensive. But hubris is not allowed. Rogue states and bioterrorist groups could easily exploit the results obtained by synthetic biologists to develop bioweapons. Thus in addition to biosafety, biosecurity, which is aimed at measures to prevent the abuse of dangerous biological agents, has become a major issue, especially for the United States and Israel. Work on pathogens and toxins needs to be tightly controlled, and the freedom of exchange of scientific information has to be balanced by security considerations. New regulations are progressively elaborated.
These articles are based on papers presented at the workshop "Synthetic Life: A Concept in Pure and Applied Biology. Historical Origins, Philosophical Questions, Current Developments, and Ethical Issues," jointly organized by Israel's National Institute for Biotechnology in the Negev and the Jacques Loeb Centre for the History and Philosophy of Life Sciences and the NIBN at BenGurion University of the Negev, on March 5-6, 2012. In order to demonstrate the various multidisciplinary exchanges at the workshop, we have decided to include the discussions following many of the papers.
We hope that after this tour of synthetic biology the reader will have a less naive, more appropriate view of what synthetic biology is, of what "synthesizing life" means, of what can be expected from this rich new domain of research and development, and also of the ethical issues that have to be closely examined.
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